Spots Global Cancer Trial Database for postmenopausal hr(+)
Every month we try and update this database with for postmenopausal hr(+) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment | NCT01144572 | Breast Cancer | 50 Years - 70 Years | AstraZeneca | ||
Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment | NCT01144572 | Breast Cancer | 50 Years - 70 Years | AstraZeneca | ||
Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment | NCT01144572 | Breast Cancer | 50 Years - 70 Years | AstraZeneca |